Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Rang in Aktien #5445
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Aktienkurs
$90.29
Zuletzt synchronisiert: 2026-08-26
Marktkapitalisierung
$2.69B
Veränderung (1 Tag)
3.30%
Veränderung (1 Jahr)
-30.11%
Land
US
Handel GeneDx Holdings Corp. (WGS)

Kategorie

Kursverlauf für GeneDx Holdings Corp. (WGS)
Höchster Schlusskurs: $80.79 am 2026-08-01

Niedrigster Schlusskurs: $329.40 am 2020-11-01
Kursverlauf der Aktie von GeneDx Holdings Corp. von 2020 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -35.49%
2025 91.72%
2024 3,422.67%
2023 -76.98%
2022 -94.30%
2021 -53.47%
2020 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$73.43 -1.11%
US
$126.42 -36.52%
AU
$68.63 -6.29%
US
$61.08 155.24%
US
$30.49 0.00%
US